Fig. 5

Pathway dysregulation associated with risk stratification. (A) GO as well as (B) KEGG enrichment analysis of differential genes in high- and low-risk patient groups. (C) Heatmap for GSVA enrichment analysis of KEGG gene set in high and low risk patient groups